Clinical Trials Unit
Stanford University School of Medicine's Center for Advanced Dermatologic Investigation is the Dermatology Department's clinical trials unit.
The Center is home to 12-15 ongoing clinical studies, investigating the safety and efficacy of new and currently available drugs and over-the-counter medications. The Center works with Stanford's own panel on medical research, leading pharmaceutical companies,and the Food and Drug Administration to safely and ethically expand the medical field's knowledge of dermatologic treatments. New studies begin regularly, and the Center continues to recruit patients with skin aging, sun damage, skin cancer (including basal cell carcinomas), psoriasis, atopic dermatitis, rosacea, and other dermatologic diseases for ongoing studies.
Skin Aging Studies
We seek to understand the human aging processes as it relates to skin on a fundamental level. To this end, our studies focus on clinical and translational research efforts ranging from: (1) the analysis of gene changes which predispose individuals to exceptionally youthful skin to (2) molecular signatures that may be biomarkers for aging skin to (3) the careful study of new candidate agents which might affect the skin aging process.
Nonmelanoma Skin Cancer
Recent advances in our understanding of basal cell skin cancer biology have enabled the development of cutting edge study drugs which combat tumor growth. We are currently home to a number of clinical trials at the forefront of potential therapy for advanced or metastatic basal cell cancer. In addition, we seek to understand the biology of basal cell skin cancers and to identify molecular predictors for treatment success.
Acne Rosecea
This is a common and frustrating chronic inflammatory condition of the face, usually affecting older individuals. The causes of this complex condition are the subject of much study. Our clinical studies seek to identify new topical or oral medications to improve the symptoms of acne rosacea.
Contact
For more information, please email dermtrials@stanford.edu
Featured Clinical Trials
CIBMTR Research Database
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies.
A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries.
Objectives:
To learn more about what makes stem cell transplants and cellular therapies work well such as:
- Determine how well recipients recover from their transplants or cellular therapy;
- Determine how recovery after a transplant or cellular therapy can be improved;
- Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy;
- Determine how access to transplant or cellular therapy for different groups of patients can be improved;
- Determine how well donors recover from the collection procedures.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making capacity,
and children. Eligible individuals may have received supportive care only, growth
factor support, HSC transplant or other appropriate medical treatment for marrow toxic
injury. Treatments applied are at the discretion of the care facility, and are not
determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
- All donors registered on the NMDP Registry who have been requested to donate a product
for a recipient are eligible to participate in the Research Database.
- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol are
included in the Research Database.
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
650-723-0822
Recruiting
Psoriasis Clinical Trials
CIBMTR Research Database
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies.
A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries.
Objectives:
To learn more about what makes stem cell transplants and cellular therapies work well such as:
- Determine how well recipients recover from their transplants or cellular therapy;
- Determine how recovery after a transplant or cellular therapy can be improved;
- Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy;
- Determine how access to transplant or cellular therapy for different groups of patients can be improved;
- Determine how well donors recover from the collection procedures.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making capacity,
and children. Eligible individuals may have received supportive care only, growth
factor support, HSC transplant or other appropriate medical treatment for marrow toxic
injury. Treatments applied are at the discretion of the care facility, and are not
determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
- All donors registered on the NMDP Registry who have been requested to donate a product
for a recipient are eligible to participate in the Research Database.
- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol are
included in the Research Database.
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
650-723-0822
Recruiting
Dermatology Clinical Trials
CIBMTR Research Database
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies.
A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries.
Objectives:
To learn more about what makes stem cell transplants and cellular therapies work well such as:
- Determine how well recipients recover from their transplants or cellular therapy;
- Determine how recovery after a transplant or cellular therapy can be improved;
- Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy;
- Determine how access to transplant or cellular therapy for different groups of patients can be improved;
- Determine how well donors recover from the collection procedures.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making capacity,
and children. Eligible individuals may have received supportive care only, growth
factor support, HSC transplant or other appropriate medical treatment for marrow toxic
injury. Treatments applied are at the discretion of the care facility, and are not
determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
- All donors registered on the NMDP Registry who have been requested to donate a product
for a recipient are eligible to participate in the Research Database.
- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol are
included in the Research Database.
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
650-723-0822
Recruiting
Pediatric Dermatology Clinical Trials
CIBMTR Research Database
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies.
A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries.
Objectives:
To learn more about what makes stem cell transplants and cellular therapies work well such as:
- Determine how well recipients recover from their transplants or cellular therapy;
- Determine how recovery after a transplant or cellular therapy can be improved;
- Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy;
- Determine how access to transplant or cellular therapy for different groups of patients can be improved;
- Determine how well donors recover from the collection procedures.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making capacity,
and children. Eligible individuals may have received supportive care only, growth
factor support, HSC transplant or other appropriate medical treatment for marrow toxic
injury. Treatments applied are at the discretion of the care facility, and are not
determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
- All donors registered on the NMDP Registry who have been requested to donate a product
for a recipient are eligible to participate in the Research Database.
- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol are
included in the Research Database.
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
650-723-0822
Recruiting
CIBMTR Research Database
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies.
A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries.
Objectives:
To learn more about what makes stem cell transplants and cellular therapies work well such as:
- Determine how well recipients recover from their transplants or cellular therapy;
- Determine how recovery after a transplant or cellular therapy can be improved;
- Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy;
- Determine how access to transplant or cellular therapy for different groups of patients can be improved;
- Determine how well donors recover from the collection procedures.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making capacity,
and children. Eligible individuals may have received supportive care only, growth
factor support, HSC transplant or other appropriate medical treatment for marrow toxic
injury. Treatments applied are at the discretion of the care facility, and are not
determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
- All donors registered on the NMDP Registry who have been requested to donate a product
for a recipient are eligible to participate in the Research Database.
- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol are
included in the Research Database.
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
650-723-0822
Recruiting
CIBMTR Research Database
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies.
A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries.
Objectives:
To learn more about what makes stem cell transplants and cellular therapies work well such as:
- Determine how well recipients recover from their transplants or cellular therapy;
- Determine how recovery after a transplant or cellular therapy can be improved;
- Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy;
- Determine how access to transplant or cellular therapy for different groups of patients can be improved;
- Determine how well donors recover from the collection procedures.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making capacity,
and children. Eligible individuals may have received supportive care only, growth
factor support, HSC transplant or other appropriate medical treatment for marrow toxic
injury. Treatments applied are at the discretion of the care facility, and are not
determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
- All donors registered on the NMDP Registry who have been requested to donate a product
for a recipient are eligible to participate in the Research Database.
- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol are
included in the Research Database.
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
650-723-0822
Recruiting